With reported numbers well in line with our estimates, Inderes’ Q1 leaves us cautiously positive.
Leaddesk again delivered solid underlying profitability in Q1 despite a muted top line.
Moberg Pharma and Karo Healthcare have announced an expansion of their licensing agreement for MOB-0...
Adtraction redovisade ökad nettoomsättning och EBITA i det första kvartalet.
Actic’s Q1 report was solid, in our view, showcasing stronger ARPM than we had anticipated, despite ...
ByggPartner Gruppen levererade ett starkt kvartal med resultat över förväntan.
Teknikbolaget FreetraileFreetrailer utmanar traditionell släputhyrning med en appbaserad och kapital...
Redeye is optimistic about the full results from ATLAS-IT-05.
DT’s Q1 revenue was slightly higher than we estimated, while EBITA was in line.
Tekova’s Q1 results exceeded expectations, reinforcing confidence that operating profit will land in...
Redeye gives a short comment on the directed issue in Ascelia.
Redeye is encouraged to see Tagmaster presenting strong numbers across the board.
* Sales +1%, EBITA adj. +13% vs. FactSet consensus * Strong organic growth, but adj.
* Adj. EBIT well above estimates at SEK 45m * Underlying performance strong, but keep an eye out for...
Redeye provides its initial take on Heliospectra’s Q1 2026 results.
AVTECH's Q1 2026 report confirmed last week's pre-announced figures without adding material new info...
Vaisala’s Q1 revenue continued to grow 7% y/y in constant currencies, and the EUR 20.
SRV issued a positive profit warning, raising its estimate for revenue and operative operating profi...
Xvivo demonstrated once again that it is back on track and generating positive free cash flow.
